Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 07.10.2026 FTAI IE000YIQZ0H6  225,002.00 USD   7,549,859.99   33.555  ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it has been selected to deliver a late-breaking oral presentation at The Liver Meeting 2026, the 77th annual meeting of the American Association for the Study of Liver Diseases (AASLD). The Liver Meeting 2026 will take place November 5-9 in Denv...

ANTIGO, Wis.--(BUSINESS WIRE)--Ace Equipment Company, a leader in industrial compactor and baler design, is excited to announce that US Recycling Equipment has agreed to join Ace Equipment as their exclusive dealer/distributor for Colorado. Headquartered in Denver, US Recycling Equipment is a well-known provider of large waste handling and recycling equipment. “We’ve had our eye on expanding our reach further west, and US Recycling Equipment came to mind immediately as the company we wanted to...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris : ABLD – ISIN : FR001400AHX6), société spécialisée dans les solutions de diagnostic moléculaire, les logiciels de santé et les services associés à la recherche clinique et au développement biopharmaceutique, informe ses actionnaires et l'ensemble de la communauté financière de la publication du dernier rapport d'analyse consacré à la Société par Jean-Pierre Loza, analyste biotech de All Invest Securities. Dans ce...

NEW YORK--(BUSINESS WIRE)--Monomoy Capital Partners, a private investment firm focused on private equity and credit investing in the middle market, announced today the completion of its platform investment in Creedence Energy Services, LLC. This transaction builds upon Monomoy’s value-added specialty chemicals distribution experience and extends its business services portfolio into the power and energy sector.Founded in 2014 in North Dakota, Creedence is a leading independent provider of product...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Emmanuel Caprais, former Senior Vice President and Chief Financial Officer of ITT, Inc. (NYSE: ITT), has been named the Company’s Senior Vice President and Chief Financial Officer effective November 4, 2026. Mr. Caprais will join the Henry Schein Leadership Team (HSLT) and report to Frederick M. Lowery, Chief Executive Officer of Henry Schein. To support a structured transition, Mr. Caprais will initially se...

PARIS--(BUSINESS WIRE)--Filigran, the company behind the open-source XTM Platform for agentic CTEM, today announced the speaker lineup for THREAD, its first annual gathering of the global cyber defense and threat intelligence community. The free event takes place Oct. 15 at Les Jardins de Saint-Dominique in Paris. Filigran’s platform has been shaped by its community, from the analysts who write connectors and share playbooks on Slack and GitHub to the security leaders who rely on that intellige...

TORONTO & SALT LAKE CITY--(BUSINESS WIRE)--SPAR Canada and ReposiTrak today announced the Canadian launch of Touchless Retail™....

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Texcell Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the “Company”), a company specializing in molecular diagnostic solutions, healthcare software and services supporting clinical research, informs its shareholders and the broader financial community that the latest equity research report on the Company, prepared by All Invest Securities, is now available. In its report dated October 8, 2026, All Invest Securities reiterates its...